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Abstract
Targeted mutations in mouse disrupt local chromatin structure and may lead to unantici-
pated local effects. We evaluated targeted gene promoter silencing in a group of six mutants
carrying the tm1a Knockout Mouse Project allele containing both a LacZ reporter gene
driven by the native promoter and a neo selection cassette. Messenger RNA levels of the
reporter gene and targeted gene were assessed by qRT-PCR, and methylation of the pro-
moter CpG islands and LacZ coding sequence were evaluated by sequencing of bisulfite-
treated DNA. Mutants were stratified by LacZ staining into presumed Silenced and
Expressed reporter genes. Silenced mutants had reduced relative quantities LacZ mRNA
and greater CpG Island methylation compared with the Expressed mutant group. Within the
silenced group, LacZ coding sequence methylation was significantly and positively corre-
lated with CpG Island methylation, while promoter CpG methylation was only weakly corre-
lated with LacZ gene mRNA. The results support the conclusion that there is promoter
silencing in a subset of mutants carrying the tm1a allele. The features of targeted genes
which promote local silencing when targeted remain unknown.
Introduction
Random integration of foreign DNA into mammalian genomes is known to provoke a
response resulting in histone modification, and marked by DNA methylation at CpG dinucleo-
tide sites, with the end result being the silencing of any potential transcriptional elements. This
silencing is particularly effective against repeat elements [1] and retrotransposon sequences
[2]. However, since the degree of silencing depends upon the site of insertion, local chromatin
organization and features also must play a role. Silencing has been problematic in the construc-
tion of vectors for random transgene insertion and expression in the creation of animal models
since vectors are often inserted as concatemers and provoke silencing [3]. Furthermore, the
potential for silencing of viral sequence is an important consideration for developing strategies
for gene therapy [4]. Silencing of engineered transgenes has been mitigated by avoiding viral
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repeat elements known to provoke silencing [4], by engineering into the vector flanking insula-
tors of DNA sequence to reduce local effects of the region on the transgene [5–6], and also by
targeting the transgene to genomic regions thought to be less responsive to the presence of for-
eign DNA, e.g., the Rosa26 locus in mice [7–8].
The majority of gene targeting experiments in mammalian systems are designed to elimi-
nate function of targeted genes, although many “knockins” have been designed to introduce
specific mutations, or to express alternative sequences under the control of the native gene pro-
moter. Often targeting vectors contain reporter sequence such as bacterial beta-galactosidase
(LacZ) or green fluorescent protein, as well as selectable markers such as a neomycin resistance
cassette in order to facilitate mutant selection in stem cell populations [9]. Since the majority of
these gene targeting events are designed to knock out, or eliminate gene expression, then the
consequences of silencing has been thought to be manageable, except that silencing of vector
elements in the stem cells might interfere with selection of targeted cells using antibiotic resis-
tance, or cause silencing of a reporter gene in the adult mutant. Strategies have been developed
to eliminate most of the foreign DNA from targeting vectors after genomic integration by engi-
neering recombinase sites flanking the selection cassette allowing the removal of vector compo-
nents at any stage in the production of the model [10–11].
An earlier report in mouse studied the silencing of a randomly integrated transgene contain-
ing LacZ driven by a ubiquitous promoter. Silencing of transgene expression was correlated
with the CpG content of the LacZ sequence in an allelic series of random integrants [12]. In
that report, decreasing CpG content of the LacZ sequence was correlated with decreased meth-
ylation of CpGs in the heterologous promoter and reduced silencing assessed by enzyme activ-
ity. These data suggest that the CpG content of reporter genes, or other elements in transgenes,
may have important local effects.
Recent large-scale mutagenesis programs in mice have created a valuable resource for study-
ing the consequence of loss of function mutations in mammalian systems. Programs such as
the European Mouse Disease Clinic (EUMODIC; www.europhenome.org; [13]); the Sanger
Center Mouse Genetics Project [14]; KOMP knockout projects [15], and other programs
recently organized as the International Knockout Mouse Consortium (www.mousephenotype.
org), are producing thousands of targeted loss-of-function mutations in mouse protein-coding
genes. Many of the targeting vectors contain both a reporter gene (LacZ) along with a neomy-
cin resistance selectable marker. These mutations will provide a valuable resource for studying
gene function, but they also provide a remarkable resource for studying the unintended conse-
quences of targeting such as silencing of the targeted gene, or effects on the expression of
neighboring genes. Since the targeting vector sequence is constant, while the location and local
environment changes with each targeting event, then it may be possible to use this resource as
a tool to better understand and characterize the mechanisms provoking transgene silencing
and by inference gene regulation.
In a pilot study characterizing LacZ reporter gene expression in KOMP mutants [16] we
noted that a subset of mutants had no LacZ staining despite gene expression surveys indicating
the gene was expressed at moderate to high levels in some tissues. This suggested to us that
these mutations may not be staining for LacZ due to promoter silencing of the targeted gene.
In order to assess this, and preliminarily evaluate if DNA methylation marks the silenced
genes, we identified a set of KOMP mutants with expected patterns of LacZ staining, and
another set of mutants with no LacZ staining although it was expected based upon other gene
expression surveys. In these two sets of mutants, we evaluated promoter CpG island methyla-
tion, LacZ coding sequence methylation, and quantified mRNA of the targeted gene and the
LacZ reporter in order to determine if gene silencing was a possible explanation for the lack of
reporter gene staining.
Reporter Gene Silencing in Targeted Mouse Mutants
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Materials and Methods
Mouse Production
Homozygous mutant C57BL/6N mice, and wild type controls, created from Knockout Mouse
Project (KOMP) targeted stem cells [9], were studied. The mutant allele was either the KOMP
CHORI-SANGER-DAVIS (CSD) “Knockout First” conditional-ready allele or a CSD “dele-
tion” mutant where the recombination removed the critical exon. These alleles are gene traps
and carry a LacZ reporter gene driven by the targeted gene promoter, along with a Neo selec-
tion marker driven by a heterologous promoter. For a description of these alleles, visit the web-
site of the International Mouse Phenotyping Consortium (IMPC: www.mousephenotype.org).
Targeting in the mice was confirmed by long-range PCR and zygosity by qPCR of LacZ coding
sequence [17]. Homozygous Mutants, and Wild Type control (WT, Control) mice, were pro-
duced by heterozygous breeding of mutants and therefore shared a common C57BL/6N back-
ground strain and were reared in identical environmental conditions. Pups were weaned at ~21
days of age, and maintained on ad libitumHarlan Teklad Global Rodent Diet #2918 and water,
in an environmentally controlled facility with a 12:12hr light:dark cycle. Mice were euthanized
at ~7 weeks of age under isoflurane anesthesia with a thoracotomy and cervical dislocation.
Tissues were rapidly harvested and quick frozen in liquid nitrogen, and stored at -80degC until
used. All animal work followed the Guide for the Care and Use of Laboratory Animals of the
Institute of Laboratory Animal Research of the National Institutes of Health and was approved
by the Institutional Animal Care and Use Committee at the University of California, Davis.
We selected six mutant lines for study based upon LacZ staining pattern in adult mutants,
gene expression patterns described in two gene expression atlases, and the presence of CpG
islands (CGI) in the promoter of the targeted gene. These mutant lines were selected from a
pool of ~90 mutant lines that were part of a pilot study of 313 mutant lines with LacZ staining,
for which we had also banked frozen tissue samples. It was noted that three of the mutant lines
had no LacZ staining even though it was expected based upon gene expression atlases using
Affymetrix Chip technology. We identified three mutant lines from the same set of ~ 90 lines,
with similar gene expression data in these other atlases which did have LacZ staining. The LacZ
staining pattern for these mutants is reported at: www.kompphenotype.org [16]. Presence of
CGIs was determined from analyses of mouse genomic DNA sequence using the UC Santa
Cruz Genome Browser (http://genome.ucsc.edu/index.html; [18]) with the criteria defining a
CGI of: a minimum length of 200bp, a minimum GC content of 50% and observed-to-expected
CpG ratio greater than 60%. Tissue expression patterns were assessed by consulting two mouse
expression atlases in the BioGPS database (www.biogps.org; [19]) and the Gene Expression
Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) available at the National Center for Bio-
logical Information. We identified three mutant lines (Lyplal1tm1a(KOMP)Wtsi, Rab32tm1a(KOMP)
Wtsi, Rgcctm1(KOMP)Wtsi) with apparent reporter silencing (Silenced) based upon the lack of
LacZ staining in mutant tissues despite expression data-bases reporting moderate to high
expression of the native gene. Three mutant lines were identified (Ninj1tm1a (KOMP)Wtsi,
Dstntm1a(KOMP)Wtsi, Arap1tm1a(EUCOMM)Wtsi) with LacZ staining as predicted by the gene
expression atlases (Expressed). Four of these alleles were the “Knockout First” allele, the Rgcc
mutant was a deletion mutant where the critical exon was deleted, and the Dstnmutant carried
a promoterless neo selection marker. All of these targeted genes had CpG islands in the pro-
moter. See S1 Table for a list of mutants and tissues, and a summary of the gene expression
data from BioGPS and GEO. For the Silenced Group of mutants we analyzed tissues with the
highest gene expression according to the databases. For the Expressed group of mutants we
analyzed 7 tissues where available including: brain, spleen, heart, kidney, liver, lung, muscle in
order to evaluate the same tissues as evaluated in the Silenced group. Plots of CpG islands in
Reporter Gene Silencing in Targeted Mouse Mutants
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the promoters of these genes are provided in S1 Fig. For each mutant line, and wild type con-
trols, RNA and DNA was isolated and processed from 3 homozygous male mice.
Experimental Design
We used qRT-PCR to assess mRNA levels of each gene in wild type control and mutant mice,
and to measure the mRNA of the LacZ reporter gene in mutants. By sequencing bisulfite-
treated DNA, we assessed DNAmethylation of CpG islands found in the promoter regions of
each targeted gene, and methylation of the LacZ reporter gene coding sequence in mutants. Fig
1 presents a schematic of the gene structure and the DNA sequences assayed for CpG methyla-
tion and for quantitating expression by qRT-PCR.
RNA Isolation and Quantitative RT-PCR
Tissue RNA isolation was performed using TRI-reagent (Sigma, St. Louis, MO) according to
the manufacturer’s protocol. To ensure homogeneous disruption, tissue samples weighing 30-
60mg were homogenized in 1ml of TRI-reagent using a bead mill at 30Hz for 45sec x2. Heart
and muscle were ground to a fine powder with a mortar and pestle on dry ice prior to bead mill
homogenization. Phase separation was achieved using 0.2mL of chloroform followed by iso-
propanol precipitation of the RNA from the aqueous phase. The remaining phases were stored
at 4degC for later DNA isolation. RNA precipitated from the aqueous phase samples was solu-
bilized in DEPC-treated water. RNA concentrations were assessed using a NanoDrop 1000
(Thermo Scientific) and quality was assessed using a BioAnalyzer 2100 (Agilent). RNA Integ-
rity numbers from the Bioanalyzer, an assessment of RNA quality, are reported in S2 Table.
All RNA samples were treated with DNase-I (Ambion, Turbo DNA-free DNase-I, Life
Technologies). A total of 6-10ug of RNA was treated in a 50uL reaction. RNA (2ug) was tran-
scribed to cDNA using the High Capacity RNA to cDNA kit (Applied Biosystems). Specific
transcripts were quantified by qRT-PCR using pre-validated IDT PrimeTime qPCR primers
and probes, or custom designed primer probe sets (Table 1). Specifics of the reaction mixes for
Dnase-I treatment, reverse transcription, and qPCR are provided in S3, S4 and S5 Tables.
Primers were designed to span exon junctions at the 3’ end of each targeted gene and to have
high specificity (S6 Table). Primer probe pairs were analyzed by serial dilution against wild
type cDNA to confirm high efficiency of the qRT-PCR reaction and these data are presented in
S2 Fig and S7 Table.
Triplicate PCR reactions for each gene, tissue and biological replicate were set-up in a lami-
nar flow hood at room temperature with a master mix containing hot start TaqDNA polymer-
ase. Amplification and qPCR measurements were performed using the Applied Biosystems
7900HT Fast Real-Time PCR System, v 2.4.1 software. Thermal cycling conditions were: 10
min at 95°C for initial denaturation; and 40 cycles of 15 sec at 95°C and 30 sec at 60°C. Each
reaction contained 2 μL of template cDNA and a reaction master mix containing 2X Thermo
Scientific Maxima Probe/ROX qPCR Master Mix (Thermo Scientific, USA), 500 nM of each
primer and 250 nM of probe. All qPCR assays were run with appropriate controls including
the Non-Template Control and minus RT control. The qRT-PCR experiments were designed
and conformed to the MIQE guidelines as described by Bustin [20]. Data were analyzed using
ΔΔCt method with Actb as the internal reference [21].
The qRT-PCR was performed with normalization to Actb gene expression and relative
quantities of transcript were determined by the delta delta Ct method. Data are presented as
the targeted gene, and LacZ reporter gene expression in each mutant tissue, relative to wild
type control gene expression in the same tissue. The mRNA abundance of the native gene was
Reporter Gene Silencing in Targeted Mouse Mutants
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comparable for the Silenced and Expressed groups with a delta Ct relative to Actb averaged
across all genes and tissues of 5.5 for the Silenced group and 4.86 for the Expressed group.
DNA Extraction, Bisulfite Treatment, PCR & Amplicon Sequencing
The general method for determining methylation status of CpGs in amplicons of bisulfite-
treated DNA has been described and validated by Masser et al. [22]. DNA was extracted from
the TRI-reagent interphase using Back Extraction Buffer (Life Technologies). Specifics of the
Back Extraction mix are presented in S8 Table. After incubation and centrifugation, the aque-
ous phase containing DNA was removed and transferred to a clean 1.5mL tube. DNA was pre-
cipitated using isopropanol. The resulting DNA pellet was dissolved in TE Buffer (Sigma).
Concentrations and quality of the DNA were assessed using a NanoDrop 1000. Genomic DNA
(5ug) was treated with bisulfite using the MethylEasy Xceed kit (Human Genetic Signature,
Australia) according to the manufacture’s protocol and eluted with 50uL of the elution buffer.
Bisulfite conversion rates were confirmed to be>98% by analyzing the cytosine to thymine
conversion for cytosines not in CpG motifs.
Amplification of bisulfite treated DNA was carried out using KAPA2G Robust HotStart
DNA Polymerase (KAPA Biosystems). We used a semi-nested PCR to produce clean defined
bands which were excised for library preparation and sequencing. Primers used for amplifica-
tion of CpG Islands are listed in Table 2. For each CpG island, from 3 to 12 overlapping ampli-
cons were sequenced. For LacZ methylation, a set of seven non-overlapping amplicons were
used covering 67% of the coding sequence. The primers used for LacZ amplification are listed
in Table 3. Each PCR reaction had unique conditions depending on the Tm’s of the primer
sets. PCR products were separated by agarose gel electrophoresis, excised and DNA was puri-
fied using E&K Gel Purification kit (E&K Scientific).
Library preparation for Next Generation Sequencing. Indexed libraries were prepared
using TruSeq Sample Prep Kit Sets A/B (Illumina RS-122-2001/2) with the protocol started at
the end-repair step with amplicons sonicated to 150-200nt length. Sequencing was completed
either with the MiSeq Platform at the UC Davis Genome Center (150nt reads/paired end), or
with the HiSeq2500 platform at the QB3-Berkeley Sequencing Core (single end 50nt). The
number of reads per amplicon passing QC averaged 37,000.
Fig 1. Schematic of Experimental Approach. A cartoon of the knockout first allele is shown with exons indicated by gray blocks numbered 1–3. The
targeted exon in this schematic is #2, with the targeting vector replacing that critical exon with an identical exon flanked with LoxP sites. Proximal to the
critical exon are placed in tandem a LacZ reporter gene driven by the targeted gene promoter, followed by transcriptional stop and polyadenylation signal,
and then followed by a heterologous promoter driving a neomycin resistance gene. The gene regions evaluated for expression by qRT-PCR and/or for
methylation by sequencing bisulfite treated DNA are indicated in brackets.
doi:10.1371/journal.pone.0134155.g001
Reporter Gene Silencing in Targeted Mouse Mutants
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Bioinformatics and Statistical Analysis of Methylation Calling. Sequencing reads were
aligned to the MM9 genomic sequence using the Bowtie2 algorithm [23], and Bismark [24],
was used for Bisulfite Indexed Genome creation and methylation calling. CpGs with reads<5
and assumed to be artifacts of PCR, and those CpGs falling into primer annealing sequence,
were not included in the analysis. For each CpG, the proportion of methylated vs. non-methyl-
ated was calculated. Alignment files were converted to BAM format using SAMtools for visual
inspection using the Integrated Genomic Viewer from the Broad Institute.
Statistics
At each specific CpG site within a CGI, the significance of differences between the mutant and
wild type allele were calculated with the non-parametric Fisher Exact test. For overall CGI dif-
ferences in methylation, the mutant and controls were compared using the Cochran-Mantel-
Haenszel statistic for categorical data. Comparing the Silenced and Expressed groups for per-
cent CGI methylation, and for relative gene expression by ΔΔCt, we used a one-tailed t-test.
Regression analysis was completed by the least mean squares method and an F statistic calcu-
lated to determine significance.
Table 1. qRT-PCR Primers and Probes.
Name Sequence and modifications IDT Assay ID Probe Purification
Method
Actb Primer 1 TGC TTG CTG ATC CAC ATC TG Mm.PT.56a.33712250.g HPLC
Actb Primer 2 AGA TTA CTG CTC TGG CTC CTA
Actb Probe /5TET/ACC GAT CCA /ZEN/CAC AGA GTA CTT GCG /3IABkFQ/
Arap1 Primer 1 GGT GTC CCA GAG TCA GAA C Mm.PT.56a.41291663.gs HPLC
Arap1 Primer 2 AAT GAA ATG CGC CGG AGT
Arap1 Probe /56-FAM/CCC TTT CCC /ZEN/TTC TCC GCC ATG TC/3IABkFQ/
Dstn Primer 1 TGA TCT ATG CAA GCT CGA AGG Designed using IDT
software
HPLC
Dstn Primer 2 CTT TTC AGC AAT ACA GGT CCG
Dstn Probe /56-FAM/CAT GAG TAT/ZEN/CAA GCA AAT GGG CCA GAA G/3IABkFQ/
3'
LacZ Probe /6FAM/CGG CAT TTT CCG TGA CGT CTC GTT/TAMRA/ Designed using IDT
software
HPLC
LacZ Primer F ATC AGG ATA TG TGG CGG ATG A
LacZ Primer R TGA TTT GTG TAG TCG GTT TAT GCA
Lyplal1 Primer
1
CAG CCT CCC ATA GAA AAT CCC Mm.PT.56a.12727909 HPLC
Lyplal1 Primer
2
TGC CCA GAA CAC CTT GAA TC
Lyplal1 Probe /56-FAM/CAA TCC ACT /ZEN/GAG CAC TTG ACA CAT ACT ATC A/
3IABkFQ/
Ninj1 Primer1 GTT AAG AAA GTC CAG CTT GGC Mm.PT.56a.43468197 HPLC
Ninj1 Primer2 CCT CAT CTC TAT CTC CCT CGT
Ninj1 Probe /56-FAM/AGC ACG CCC /ZEN/ACT CCT ATC TGC /3IABkFQ/
Rab32 Primer 1 GCA AGC ATG TTT TCC ACT AGG Mm.PT.56a.29895651 HPLC
Rab32 Primer 2 CAA CAG CCA GAG TCC TTC C
Rab32 Probe /56-FAM/ATA TAA ACA /ZEN/TCG ACG AGG CCA CCC G/3IABkFQ/
Rgcc Primer 1 TCC TTG CTT CAC ATA CTT GCT Mm.PT.56a.13340638 HPLC
Rgcc Primer 2 AAT TCT CCA ACC AAC TCC TCT C
Rgcc Probe /56-FAM/AGT GTC ACC /ZEN/TAA TTT GGC TTT CCG AGG /3IABkFQ/
doi:10.1371/journal.pone.0134155.t001
Reporter Gene Silencing in Targeted Mouse Mutants
PLOS ONE | DOI:10.1371/journal.pone.0134155 August 14, 2015 6 / 17
Table 2. CpG Island Primers.
Primer Sequence Sequenced Amplicon length
Arap1-BS-F1 GTAAGTTAAGGATAAAGGAGAGATATAAAT 224
Arap1-BS-R2 CAACAACCTCACTAACCTATTTTAAAC
Arap1-BS-R3 CCCCAAACAAAAACRCRCACCAAATAAC 344
Dstn-BS-F1 GGGTGGTTTTGTGGAAGTAGT 225
Dstn-BS-R1 CTACACAATTTTCCTCCTTCCTAAAAC
Dstn-BS-F2 GGAATAAGYGTTGATTTATATAGTATTTTG 170
Dstn-BS-R2 CCRATAAACRAATACTCTACTTAAC
Dstn-BS-F3 GGTTTTTGAGAGTYGTTTTGAGAGT 150
Dstn-BS-R3 CTCCRAAAAATCTAACCCTACCCTAAAAAC
Dstn-BS-F4 GGTGGYGATTTTTATGTATGGGTAAAGGT 162
Dstn-BS-R4 CCCCACCCAAAAATCCCAATAATC
Dstn-BS-F5 GGGGTTTTTAGTTGTTTGGAGATTATTG 230
Dstn-BS-R5 CRCCCGAAAATCACTCACCATATTC
Lyplal1-BS-F3 GGAAGAGGATGAAGATGAGTGTTATATAGAAAG 173
Lyplal1-BS-R3 CCTCCRCCATAACTACTATACCCAAC
Lyplal1-BS-F4 GGGTYGGAGATTAYGAGATTGTAATGTATTTGAGT 147
Lyplal1-BS-R4 CRCATACRCACACCCATACTAATACTACTTACCTAC
Ninj1-BS-F1 GGGGATATTAAGGTYGTTGGAGAAGTGT 198
Ninj1-BS-R1 CTCATACTCCTCAATACCCRACTCCATAATAC
Ninj1-BS-F2 GGGTGYGTTTAGGTYGTGTGTTG 177
Ninj1-BS-R2 CCRAACCAAACRCCCACAAATAC
Ninj1-BS-F3 GTTTYGGTTGTTGTGTGATTTTGGT 162
Ninj1-BS-R3 CCCRACRCCTCTACCTACCTACTATACTAAC
Ninj1-BS-F4 GTTTGATTTGTTTTTAGYGTAAGTGGTGGT 184
Ninj1-BS-R4 CCCRACRCCTCTACCTACCTACTATACTAAC
Ninj1-BS-F5 GGTTGGTATTATTTTTYGGGTGGAGAAGGTT 156
Ninj1-BS-R5 CCCTTATCACTACTACAAACRACCGTATAATCAC
Ninj1-BS-F6 GGTTGGAAGTTAGTATTAGGTAGATAG 198
Ninj1-BS-R6 CAAACATCCRACCATCRCTATAACCTTA
Rab32-BS-F1 GTTTAGGTAGAGGAAAGGATAGAGAAGAAT 142
Rab32-BS-R1 CACCAACTCTTCTCCCAACACT
Rab32-BS-F2 GAGYGTTTTGTTGTTTTAGTTGAGAATTTTG 181
Rab32-BS-R2 CCCTAAACCRTAACACCCATAAC
Rab32-BS-F3 GAGTTYGTYGATGATTAGTATTTTAAAGAGGTGT 161
Rab32-BS-R3 CACCCAAACTATTCTAAACCAACAAC
Rgcc-BS-F1 GAGTTTTAGGAAGTTTGAGTTTGAG 231
Rgcc-BS-R1 CCCCTCCAAATACCCTCTATAC
Rgcc-BS-F2 GGTTTGTAGYGGTYGYGGAGTTTATG 178
Rgcc-BS-R2 CRCRTAAAATAAACTAAATAACTTCCAAACTTTC
Rgcc-BS-F3 GGAGGAGAAGAAGTTTTYGTGGGTT 199
Rgcc-BS-R3 CTACCCACCCTTCTATCCTCCATC
Rgcc-BS-F4 GGAGAYGGGATGTTAGGGTGATG 200
Rgcc-BS-R4 CCRCCCTCAACGCAAAACAATC
Rgcc-BS-F5 GTAGAGGTGGAGAAGATATTTTTAAATAGGT 207
Rgcc-BS-R5 CCCCTACCRATAACTATAAAACGAAATAAC
Rgcc-BS-F6 GAGTTTGAGYGTTAGTTATTYGTTTGAGT 234
Rgcc-BS-R6 CTCTAATACCCRCAAAAACACTTCCTTAAATC
doi:10.1371/journal.pone.0134155.t002
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Results & Discussion
Overall, relative mRNA quantity for the targeted gene, and mRNA for LacZ, was less in the
Silenced compared with the Expressed group (Fig 2). In the Silenced mutants (Lyplal1, Rab32,
Rgcc), the targeted gene mRNA and LacZ mRNA was 0.6 ± 1.21% and 10.4 ± 11.6% of Wild
Type Control native gene, whereas for the Expressed group of mutants (Ninj1, Dstn, Arap1)
mRNA for the targeted gene and mRNA for LacZ were 32.9 ± 20.5% and 53.4 ± 43.9% of con-
trols (all data are presented as mean ± standard deviation)
In wild type control animals, methylation of the CpG islands found in the promoters of
genes characterized in both Silenced and Expressed groups was very low, 0.71 ± 0.25% and
0.66 ± 0.44% respectively. However, in the mutant Silenced group the average promoter meth-
ylation was 3.98 ± 3.21%, but promoter methylation remained very low in the Expressed group
of mutants at 0.85 ± 0.67% (Fig 3).
The methylation data at each CpG site within each CGI was analyzed using a non-paramet-
ric test (Fisher Exact test). Since the average number of reads per amplicon was 37,000, this sta-
tistical method had the power to score as significant (p< 10−6) even very small differences in
methylation. When the Cochran-Mantel-Haenszel test was used to compare Mutant versus
Wild Type control there was a significant difference at p< 0.0001 for each island in every tis-
sue. However, it was clear from inspection of the data (Fig 3) that there were differences in the
overall percent methylation in the Silenced compared with the expressed group.
The methylation and gene expression data for each group were averaged across mutants
and tissues and compared by t-test and the data are presented in Fig 4. There were significant
differences between the Silenced and Expressed group for the targeted gene mRNA abundance
(p<0001), for LacZ mRNA (p<0.01), and significant differences for the percent methylation of
the promoters (p<0.0001).
These data support the hypothesis that in a subset of targeted mutants carrying this allele
there is a reduced expression of the reporter gene and the increased methylation of the promot-
ers of the Silenced group supports the conclusion that this was due to promoter silencing. Not
only was LacZ mRNA lower, mRNA for the targeted gene was significantly lower in Silenced
compared with Expressed mutant tissue (Fig 4). The presence of mRNA for the gene-trap
alleles is not surprising and likely represents splicing between the neo or LacZ reporter
Table 3. LacZ primers used for Amplifying Reporter Gene Sequence.
Primer Sequence Size bp
BS2-LacZ-F2 GTTTTGTTTGGTTTTYGGTATTAGAAG 292
BS2-LacZ-R2 CCCRTTACACCACAAATAAAAC
BS2-LacZ-F4 GTTTGTYGTTTGAATTTGATTTGAGYGCATTTTTA 284
BS2-LacZ-R4 CCCTACCATAAAAAAACTATTACCCRTAAATAATCAC
BS2-LacZ-F6 GTTGATTGAAGTAGAAGTTTGYGATGT 315
BS2-LacZ-R6 ATCAAACRATTCATTAACACCATACC
BS2-LacZ-F8 GAGTGTGATTATTTGGTYGTTGGGGAATGAATTAGGTTA 324
BS2-LacZ-R8 CCCAAACRAAACCRCCCTATAAACRAAAATACTAAC
BS2-LacZ-F10 GGAAGTAAAATATTAGTAGTAGTTTTTTTAGT 290
BS2-LaTZ-R10 CTAATATACCCRACTTCTAACCATAC
BS2-LacZ-F12 GAGTTGGGTAATAAGYGTTGGTAATTTAAT 259
BS2-LacZ-R12 AATCAACACCRCATCAACAAATATATCTA
BS2-LacZ-F14 GGTAAATTGGTTYGGATTAGGGTYGTAAGAAAATT 294
BS2-LacZ-R14 CCRTCRATATTCAACCATATACCTTCTTC
doi:10.1371/journal.pone.0134155.t003
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sequence and 3’ exons of the targeted gene, or leakiness of the gene-trap allele [25–28]. Of
interest is that the quantity of targeted gene mRNA assessed by qRT-PCR was significantly
lower in the Silenced compared with Expressed mutants.
As reviewed by Deaton & Bird [29] and by Illingworth and Bird [30], CpG islands (CGI) are
regions of DNA rich in CpG sequences compared with the rest of the genome. CGIs are found
in the promoter regions of ~70% of all genes. Generally, the cytosines are not methylated in
these CGIs in either expressed or inactive genes, while there is a high percentage of CpGs meth-
ylated outside of CGIs. It is not known what protects promoter CGIs from methylation of the
CpG cytosines but likely histone modifications and transcription factor binding are protective.
However, when methylation of CpGs does occur within CGIs this is strongly correlated with
the silencing of transcription. Methylation of CpGs may not be the initiating event of silencing
but instead may mark chromatin modifications with cytosine methylation locking in and stabi-
lizing the silenced state. CpG methylation is of significant importance during development
[31], for X inactivation [32], imprinting [33], and is observed in silenced tumor suppressor
genes in cancer tissue [34]. As noted in the introduction, CpG methylation has also been asso-
ciated with the silencing of transgene promoters.
Fig 2. RQmRNA of Targeted Genes and LacZ. Silenced and Expressed group targeted gene expression, and LacZ reporter gene expression, are
presented as Relative Quantity (2-ΔΔCt) values relative to native gene expression in Wild Type Control animals for each mutant gene and tissue. Each data
point is the average of three biological replicates, with the qPCR done in triplicate.
doi:10.1371/journal.pone.0134155.g002
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We report here a small but statistically significant increase in CGI methylation in the pro-
moters of targeted genes that did not have LacZ staining. This promoter methylation was cor-
related with LacZ methylation in the Silenced group (R2 = 0.74, p< 0.013; Fig 5). However, in
the Silenced group there was only a weak and non-significant correlation of promoter
Fig 3. Methylation of CpG Islands in Targeted Genes. Percent methylation of CpG islands (CGI) in Mutant tissues and in Wild Type controls are presented
for the Silenced and Expressed groups. Although the differences were small for some CGIs the Cochran-Mantel-Haenszel test determined that each mutant
CpG island was significantly different from the correspondingWild Type Control island percent methylation.
doi:10.1371/journal.pone.0134155.g003
Fig 4. Targeted Gene Expression, Reporter Gene Expression and Promoter Methylation. Individual mutant and tissue values were averaged across the
Silenced group (n = 7) and the Expressed group (n = 18) and compared by t-test. * = p<0.01; ** = p<0.0001. Date are presented as means +/- standard
errors. The Silenced group had significantly lower expression of the targeted gene and the LacZ reporter and had higher percent methylation compared with
the Expressed group.
doi:10.1371/journal.pone.0134155.g004
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methylation and LacZ mRNA (R2 = 0.22; Fig 5). This suggests that there are certainly other fac-
tors, in addition to promoter methylation, that are contributing to the silencing of gene expres-
sion in the Silenced group. As would be expected since the overall promoter methylation was
uniformly very low in the Expressed group of mutants and tissues, there was no correlation
between promoter and LacZ methylation, or between promoter methylation and LacZ mRNA.
Although the amount of overall methylation of the promoters in the Silenced group was ele-
vated it was still quite low. However, the pattern of methylation may be the important factor in
driving silencing and not the overall percent methylation at a CGI. There is precedent that
Fig 5. Correlation between Promoter and LacZ Coding SequenceMethylation, and between Promoter Methylation and LacZ Expression in
Silenced Mutants. A significant positive correlation was observed between LacZ and CpG%methylation with a p < 0.013. Although the correlation between
CpG%methylation and LacZ gene expression was negative as expected, this did not reach statistical significance.
doi:10.1371/journal.pone.0134155.g005
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methylation of specific CpG sites in promoter regions correlates with silencing. For example,
Furst et al. [35] have reported that methylation status of a single CpG site in the promoter for
the estrogen receptor alpha gene is correlated with transcriptional silencing. In a genome wide
survey, Medvedeva [36] found that methylation of ~16% of CpGs in CGIs near the transcrip-
tional start site were correlated with gene repression. However, these CpGs were generally not
found at transcription factor binding sites. Of the three CGIs in the promoters of the Silenced
group, only one had a uniform increase in CGI methylation across all the CpG sites in the
mutant (Lyplal1). The other two CGIs had increased methylation in only a subset of CpGs. The
patterns of CpG methylation for each of the silenced promoters in representative tissues are
presented in S3 Fig.
LacZ was highly methylated for all of the mutant alleles and tissues (Fig 6). The percent
methylation of LacZ CpGs in the Silenced group was 21.9 ± 18.5%, whereas the percent meth-
ylation in the Expressed group was 45.4 ± 18.3%. This was significantly different by t-test
(p< 0.008). Gene bodies (exons and introns) are generally CpG poor relative to the rest of the
genome, but the CpGs in gene bodies are highly methylated although the functional conse-
quences of gene body methylation are not understood [37]. Gene body methylation does not
block transcription or elongation [37]. In fact, there are reports that methylation of gene bodies
is correlated with high gene expression on the active X chromosome [38]. Aran et al. [39] dem-
onstrated that actively expressed gene bodies are hypermethylated compared with flanking
sequences and compared with gene bodies that are not expressed. Whereas, Jjingo et al. [40]
showed that gene bodies with the highest level of methylation are the genes with mid-level of
expression, and genes with low and highest levels of expression have low methylation levels.
Therefore, the relationship between exon/intron methylation and gene expression is not a sim-
ple one. One possibility is that the differential LacZ coding sequence methylation in the
Expressed and Silenced group also contributed to the differential reporter gene expression in
these two groups, with the higher methylation of LacZ coding sequence in the Expressed group
leading to higher transcription. This may be one additional factor, along with promoter silenc-
ing, responsible for regulating reporter gene expression in this system but further work will be
needed to determine this.
This study does not definitively prove that the presence of the LacZ reporter with a high
CpG content is causal for the silencing of the targeted promoter in the Silenced mutants as
would be suggested by the data from Chevalier-Mariette [12]. LacZ sequence has a higher GC
content and more CpGs than most of the mammalian genome, containing 3061 nucleotides, a
GC content of 56.3% with an observed CpG over expected CpG ratio of 1.19. The presence of
unprotected CpGs in the LacZ coding sequence may recruit methylation factors which may
extend their methylation activity to nearby promoter CGIs. However, these mutants also car-
ried a Neo selection cassette which is high in GC% and CpG content. Neo coding sequence
length is 794nts, the GC content is 59.9%, and the observed-to-expected ratio of CpGs is 1.03.
A number of factors could be at play in determining if a promoter is silenced with this targeting
vector, including the presence of the exogenous high CpG content DNA as well as unique char-
acteristics of the targeted gene sequence and local chromatin environment. It is likely not sim-
ply the presence of the LacZ coding sequence in a permissive environment producing
silencing.
We looked for unique features of the Silenced vs. the Expressed gene structure/organization,
vector insertion, and histone modifications in mouse genome screens that might explain why
the CSD targeting vector insertion results in silencing in some genes but not others. All of the
genes targeted in this study contain multiple exons, and the size and location of the promoter
CGI is similar among the mutants. The CGIs were of similar length, GC content, and ratio of
observed to expected CpGs. The vector insertion site tended to be closer to the CGIs in the
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Silenced compared with the Expressed group, and two of the vector targeting arms overlapped
with the CGIs in the Silenced group while none of the Expressed group vectors had CGI
homology arm overlap. Overlapping vector arms could have resulted in disruption of the CGIs,
but we found no differences in CGI sequence compared with the reference genome. We also
found that two of the promoters in the Silenced group, and none of the promoters in the
Expressed group, were associated with H3K27 histone trimethylation, a marker of Polycomb
silencing [41]. These studies were done in wild type mouse tissues and the H3K27 methylation
may indicate that these specific genes are predisposed to silencing. Other than these findings,
we found no other differences in gene structure, vector characteristics, or histone marks that
might explain differences in silencing between the Silenced and Expressed groups of mutants.
However, the sample used is too small to make generalizations. Future studies with larger sets
of genes, may reveal structural elements correlated with promoter silencing.
The focus of this report is the promoter silencing of the targeted gene in these mutants.
However, the possibility exists that the targeting vector may influence the expression of genes
in close proximity. This had been reported in other targeted mutant mouse models, either due
to disruption of intragenic regulatory elements [42–43], or the presence of the heterologous
promoter and neo sequence [44–46]. In a recent report in a targeted Slc25a21mutation using
the same vector as described in the present report [47], they observed reduced expression of a
nearby gene. Using an allelic series including the intact vector, and a vector with the neo cas-
sette removed but retaining the LacZ reporter, they demonstrated that the presence of the Neo
cassette was responsible for producing the phenotypes of dental and craniofacial abnormalities
along with otitis media and hearing impairment. The presence of the Neo decreased the expres-
sion of the 3’ Pax9 gene, and a previous publication of a mutation in mouse Pax9 recapitulated
some of the same phenotypes. Examining the GEO mouse expression databases revealed
expression in kidney, liver, spleen and other tissues for mouse Slc25a21. However, the Slc25a1
adult mutant has no staining for the LacZ reporter except in the testis (See: https://www.
sanger.ac.uk/mouseportal/), which could be nonspecific or ectopic. Therefore, the down
Fig 6. Methylation of CpGs in LacZ Coding Sequence.%methylation of CpGs in the LacZ coding sequence is presented for each mutant and tissue, with
Silenced mutants in red and Expressed mutants in blue. There was a significant overall difference in average percent methylation of LacZ coding sequence
between the two groups (t-test; p < 0.001).
doi:10.1371/journal.pone.0134155.g006
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regulation of the neighboring Pax9 gene in the Slc25a21mutant may also be associated with
down regulation of the targeted promoter.
Conclusions
In a subset of targeted gene trap mouse mutants, we have observed the apparent silencing of
the targeted gene promoter reflected by reduced LacZ mRNA from the reporter gene. In this
subset of mutants, the degree of LacZ methylation is significantly correlated with CGI methyla-
tion, but CGI methylation is only weakly negatively correlated with LacZ mRNA levels. The
data support the hypothesis that presence of the exogenous DNA in the targeting vector, inter-
acting with local chromatin environment, may lead to promoter silencing of the target and that
this silencing is marked by CpG methylation. These findings emphasize the need to consider
the local effects of targeting vectors on reporter gene expression, and possibly local effects on
neighboring genes. Although we believe that local promoter silencing is a relatively rare event
in mutants carrying this allele, additional work will be required to define the frequency of these
events, and also to understand which features of the targeted gene environment, interacting
with the vector, promote silencing.
Supporting Information
S1 Fig. Visual representation of CGI’s of Expressing and Silenced groups. CpG sites in each
cartoon are represented by vertical lines. The number of nucleotides covered by the images is
indicated in the upper right corner of each CpG plot. Flanking the actual CpG islands in these
plots are 200nts not included in the island definition.
(TIF)
S2 Fig. qRT-PCR Probe Efficiency for Actb, LacZ, Arap1, Dstn, Ninj, Rgcc, Lyplal1 and
Rab32. Each plot point is the Ct value obtained using serious dilution of target cDNA. Effi-
ciency values were measured using the Ct slope method constructing a plot of Ct vs. log cDNA
dilution factor.
(TIF)
S3 Fig. CpG Methylation Wild Type vs. Mutant.Methylation percent representation of indi-
vidual CpG sites in the promoter regions of Silenced group.
(TIF)
S1 Table. Mutants, Tissues, LacZ Staining, and Gene Expression. Columns under BioGPS
and GEO indicate fluorescent intensity of the signal from probes for the specific gene tran-
scripts. Numbers separated by slashes indicate values for different probe-sets, hyphenated
numbers indicate range of values from different probe-sets.
(DOCX)
S2 Table. Total RNA quality.Quality evaluation of pooled biological replicates of RNA sam-
ples with BioAnalyzer prior to reverse transcription to cDNA.
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S3 Table. Conditions for DNAse Treatment
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S4 Table. Reverse Transcription. Reagents, their amounts and temperature cycling conditions
used for reverse transcription.
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S5 Table. qPCR Reaction Conditions. Reagents and their amounts for qRT-PCR reaction.
(DOCX)
S6 Table. qRT-PCR probe design. Information for number of exons for all the genes investi-
gated, NCBI accession numbers, in-silico specificity, primer/probe annealing location, length
of an amplicon, and splice variants targeted.
(DOCX)
S7 Table. Table of Primer/Probe Efficiencies. Efficiency values that were used to correct rela-
tive expression for genes of interest. Efficiencies were determined using the Ct slope method
for which a plot of Ct vs. log cDNA dilution factor was constructed.
(DOCX)
S8 Table. Back Extraction Buffer. Reagents and their amounts for DNA isolation from inter-
phase and organic phase left after RNA isolation.
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